Best Semaglutide Vendors for Research in 2026

In June 2025, the FDA raided Amino Asylum's warehouse. Nine months later, Peptide Sciences went dark overnight, erasing 15 years of semaglutide supply history. The GLP-1 research market did not collapse. It thinned.

The post-enforcement landscape split into two camps: vendors with genuine quality infrastructure, and rebranded gray operators betting researchers would not ask hard questions. One finding makes the stakes concrete. Finnrick's pre-closure audit of Peptide Sciences showed 99.47% to 100% purity but 9% to 28% vial underfill. Purity and dose accuracy are separate problems.

This ranks the best semaglutide vendors confirmed carrying stock in April 2026. We evaluated seven operators on testing rigor, supply stability, and documentation transparency. Every vendor here publishes a COA and has been reachable for batch-level follow-up in the last 30 days. For the compound itself, see our semaglutide molecule profile, and our vendor evaluation methodology explains the grading.

1. Apollo Peptide Sciences: The Semaglutide Specialist

• Founded: May 2024
• Location: Oxnard, California
• Focus: GLP-1 and metabolic peptides
• Testing: HPLC + Mass Spectrometry
• Semaglutide: Core product

Most vendors sell semaglutide the way a convenience store sells motor oil: it is on the shelf because people ask. Apollo is different. GLP-1 peptides are the reason the lab exists.

That specialization matters. Semaglutide runs 4,113 daltons with a C18 fatty acid side chain stapled to a 31-amino-acid backbone. Short peptides can be characterized by HPLC alone. Semaglutide cannot. High-resolution accurate-mass mass spectrometry is the gold standard for this molecule because it distinguishes near-isobaric impurities that HPLC retention time will file away as the target compound. Apollo runs both HPLC and MS on every batch. That is the correct workflow, not a nice-to-have. For verification detail, see our COA verification framework.

Apollo's launch timing matters too. Opening in May 2024 means the lab was built after FDA enforcement signals around GLP-1 compounders were already unambiguous. Vendors who set up shop in that window wrote clean compliance postures into the walls. Older vendors have been retrofitting.

The honest trade-off: Apollo's ~23-peptide catalog is narrow. Multi-compound protocols need a second vendor for BPC-157, TB-500, or the rest of the stack. Pricing runs premium relative to bulk operators, the cost of running HRAM-MS on a focused line.

Best for: researchers whose protocol is GLP-1 centered and who want lab methodology matched to the molecule.

Skip if: you need single-vendor sourcing for a ten-compound stack.

2. Core Peptides: Community-Trusted with Independent Verification

• Location: Orlando, FL
• Reviews: 4.8 stars across 279 verified reviews (93% five-star)
• Testing: Janoshik and Colmaric (dual independent labs)
• Catalog: 78+ peptides
• Semaglutide: In stock

279 reviews exceeds what most boutique peptide vendors log in their entire existence. Core Peptides hit that number while holding a 4.8-star average and publishing COAs from two independent labs.

The dual-lab workflow is the signal. Janoshik Analytical and Colmaric Analyticals are both recognized in the research peptide space. Using both means genuine cross-validation, or at minimum a willingness to pay double COA costs to prove the work. Single-lab COAs are the norm. Two named labs is rare. Naming them specifically is rarer still.

Review volume at this scale is hard to fabricate. Vendors with 50 polished five-star reviews answer different questions than a 279-review vendor holding consistent scoring across years of shipments. Community reports indicate shipping is consistent and semaglutide batches track posted COA values.

Core ships 5mg lyophilized vials, the industry default for semaglutide research. Lyophilized product tolerates transit without dry ice up to 86°F, so standard ground shipping works. Reconstitution uses the normal BAC water protocol. Catalog breadth (78+ peptides) means a single-vendor research stack is feasible without sacrificing the dual-lab paper trail. See Core Peptides' full scorecard in our vendor directory.

The verdict: for the highest trust-per-dollar ratio on this list of best semaglutide vendors, Core Peptides is the default pick. The 93% five-star rate across 279 reviews is the reviewer-distribution signal worth paying for.

3. Ascension Peptides: Triple-CLIA-Verified Testing

• Location: Castle Rock, CO
• Testing: Three CLIA-certified labs (including SafeCert)
• Reviews: 4.8 stars across 72 verified reviews
• Semaglutide: Available, premium pricing
• Verified purity: 99.1% to 99.7%

If your protocol requires documentable chain-of-custody testing, Ascension is the shortest path to a defensible answer.

CLIA certification holds the testing lab to federal quality standards for human clinical diagnostic work. It is not required for research peptide COAs, which is exactly why it functions as a trust signal when a vendor bothers with it. Ascension uses three separate CLIA-certified labs. That redundancy matters for semaglutide specifically because the FDA has flagged salt-form versus free-base ambiguity as a recurring issue in compounded GLP-1 products. CLIA-lab HRAM-MS distinguishes acetate-bound from free-base semaglutide. An unclear salt form means an unclear active dose, since salt forms require NPC (net peptide content) correction to match free-base weighing.

The trade-off is price. Ascension sits at the premium end. EZ Peptides lists 5mg semaglutide at $34.99. Ascension runs materially higher. Triple CLIA testing costs money and the vendor does not hide that in the pricing.

Review count is 72, but concentrated volume on a 4.8 average works differently than 72 cherry-picked reviews. Negative experiences at a vendor this small would pull the rating visibly. They have not. CLIA certification detail lives in our COA framework.

Why triple-lab testing matters for semaglutide: a single lab can miss salt-form contamination or endotoxin above spec. Redundancy catches the miss.

Best for: researchers who need external documentation to survive scrutiny.

Skip if: budget is the binding constraint and the work is early-stage feasibility.

4. Orbitrex Peptides: Finnrick A-Rating and 99%+ Purity

• External grade: Finnrick A-rating
• Purity: 99%+ on tested batches
• Reviews: 4.8 stars across 48 verified reviews (zero negative)
• Semaglutide: Confirmed in catalog
• Pricing: mid-tier

Vetting peptide vendors takes real time. Read COAs, cross-check batch numbers, look up testing lab credentials, then look up the lab that certified the lab. Orbitrex short-circuits most of that work: Finnrick already ran the audit.

Finnrick is an independent blind-testing program that purchases product the way a researcher would, ships it to an unaffiliated lab, and grades the result. An A-rating means the sample came back clean on purity. Important caveat: Finnrick's own audit of Peptide Sciences showed 99.47% to 100% purity while vials were underfilled 9% to 28%. An A-rating grades the molecule in the vial. It does not grade the amount of molecule in the vial. Verify fill weight separately by reconstituting and back-calculating against expected concentration.

With that context, 99%+ purity on a 4,113 Da peptide is meaningful. The four-point gap between 95% and 99% is not cosmetic for a molecule this size, because synthesis byproducts at this length are often pharmacologically active rather than inert carryover.

48 reviews is a smaller base than Core, but Finnrick's external validation substitutes for review scale. The trust signal comes from a third party running the test, not review count. Zero negative reviews across 48 is also rare. For sourcing context, see our semaglutide sourcing guide.

Quick comparison: versus Core Peptides, Orbitrex has less review volume but more external validation. Versus Ascension, Orbitrex gives you blind-test grading at lower cost, without CLIA-lab documentation.

5. Limitless Biotech: Biggest Catalog, GLP-1 via Registration

• Location: Gulf Breeze, FL
• Accreditation: BBB accredited since 2020
• Catalog: 90+ compounds
• GLP-1: Available via researcher registration
• Track record: Longest-running operator on this list

Semaglutide is not on the front page of the Limitless Biotech catalog. That is not an oversight.

GLP-1 products sit behind a researcher registration step. The ordering flow filters out casual buyers before the catalog page loads. This is a compliance signal, not an inconvenience. The vendor is visibly not advertising semaglutide to the public, which tracks with the posture long-tenure operators adopt once enforcement starts moving. For serious researchers, the registration is a one-time hurdle and the ordering experience on the other side is cleaner than most.

Catalog breadth is the other reason Limitless shows up here. 90+ compounds means a multi-compound protocol can source semaglutide plus BPC-157, TB-500, CJC-1295, and the rest of a typical stack from one vendor. That simplifies record-keeping and reduces COAs to track. Limitless names TrustPointe Analytics LLC as its COA lab, which is the transparency floor we expect.

Track record matters too. The seven-plus vendors that went offline in 2025 were mostly short-tenure operators with thin compliance documentation. Limitless has been BBB accredited since 2020, which is not a proxy for testing rigor but is a proxy for supply stability. Trustpilot shows a weaker picture at 3.1 stars across ~150 reviews, which readers should weigh against the longer operating history. Full profile in our vendor directory.

Best for: multi-compound protocols where single-vendor sourcing saves real time.

Skip if: you want GLP-1-specialist testing methodology or a walk-in-the-front-door ordering experience.

6. EZ Peptides: Lowest Confirmed Price, Transparency Gap

• Semaglutide price: $34.99 / 5mg vial
• Testing: Third-party COA published, lab name undisclosed
• Transparency: QR-code COAs, lab identity opaque

Every researcher has priced semaglutide and wondered if $34.99 per 5mg vial is too good to be true. The honest answer: it is not a scam, but it is not the same product Ascension is selling.

Start with price context. Premium vendors on this list charge $80 to $120 per 5mg vial depending on volume. EZ lists at $34.99. At protocol scale, that gap compounds fast. For a six-month feasibility study across multiple dose arms, the vendor choice can swing total spend by several multiples.

The transparency gap: EZ publishes COAs via QR code. The COAs do not name the testing lab. Compare that to Core Peptides, which names Janoshik and Colmaric specifically, or Ascension, which names three CLIA-certified labs. Unnamed-lab COAs cannot be cross-verified because there is no lab to call and confirm the batch number against. This does not mean EZ is lying on the documents. It means researchers cannot independently audit the claim, which is a meaningful difference when the work has to hold up to outside review.

When is the trade-off acceptable? Preliminary feasibility work, dose-finding, and budget-constrained early-stage protocols where the researcher plans to re-source from a named-lab vendor once the basic protocol is validated. If you are writing results for an external audience, skip this tier. Our methodology flags unnamed-lab COAs as a transparency gap, not a disqualifier.

The lab-naming test: if a vendor publishes a COA but will not name the lab, ask directly before ordering at scale. A vendor that will not answer that in email is not a vendor for production work.

Best for: pilot work, feasibility runs, researchers on a price-first constraint.

Skip if: documentation has to survive external review.

7. Polaris Peptides: 10mg Vials and HPLC-MS Testing

• Vial size: 10mg lyophilized
• Testing: HPLC + Mass Spectrometry
• Claimed purity: >99%
• Positioning: Extended-protocol specialist
• Semaglutide: Confirmed in catalog

Run a semaglutide protocol longer than a month and you know the drill. Reconstitute the 5mg vial, use within 28 days, discard the rest, pull a new vial. Polaris's 10mg vial doubles the runway per reconstitution.

This is not just convenience. Reconstituted semaglutide in BAC water is stable for 28 days at 2 to 8°C. A 10mg vial reconstituted into 4mL of BAC water yields 2.5mg/mL at double the working volume of the standard 5mg / 2mL prep. Fewer reconstitution events means fewer sterility-break opportunities, fewer septum punctures per vial, and fewer transitions where the sample sits at room temperature during prep. For protocols running longer than two months, the math matters.

Polaris runs HPLC plus mass spectrometry, the correct methodology for this compound, and claims >99% purity on batches. The 4,113 Da molecular weight plus C18 fatty acid chain puts semaglutide in a range where HPLC alone misses characterization details MS catches. Polaris running both on a non-specialist catalog is a better signal than catalog breadth alone would suggest. For compound detail, see our semaglutide molecule profile.

Trade-offs are real. 10mg vials cost more per unit than 5mg, although the per-milligram price usually drops. Polaris has a smaller review base than Core, so reviewer-signal is thinner. Neither is a reason to skip the vendor, but both are worth noting.

The verdict: if your protocol runs longer than 28 days and you want the correct testing methodology without paying CLIA premiums, Polaris is the specific answer.

FAQ

Do any semaglutide research vendors ship with cold-chain packaging?

Most do not, and for lyophilized semaglutide that is generally fine. Freeze-dried semaglutide tolerates transit temperatures up to 86°F (30°C) without measurable loss of activity. The compound only requires cold storage (2 to 8°C) once reconstituted in BAC water, and must not be frozen after reconstitution. A few premium vendors offer optional ice-pack shipping for summer transit in hot climates, usually as an upcharge rather than default.

What is the difference between free base and salt-form semaglutide?

Free-base semaglutide is the pure peptide. Salt-form (typically acetate) is the peptide bound to a counterion, which adds mass without adding active compound. A 5mg acetate-salt vial contains less than 5mg of active semaglutide unless the label corrects for NPC (net peptide content). The FDA has flagged salt-form mislabeling as a recurring compliance issue among GLP-1 compounders. Confirm which form the COA reports and whether NPC correction is applied to the stated dose.

What should a semaglutide COA include for research use?

A usable semaglutide COA names the testing lab, lists the batch or lot number, reports purity (98%+), states the analytical method (HPLC plus MS is appropriate for this molecule), and specifies whether the reported weight is free base or salt-form with NPC correction. Endotoxin testing is a plus. Unnamed-lab COAs cannot be independently verified, which is why we flag them as a transparency gap.

How do you reconstitute lyophilized semaglutide?

Standard protocol is bacteriostatic water (BAC water). For a 5mg vial, 2mL of BAC water yields 2.5mg/mL. For a 10mg vial, 4mL yields the same concentration with more working volume. Add BAC water slowly down the side of the vial rather than directly onto the lyophilized powder, then swirl (do not shake). Store reconstituted product at 2 to 8°C and use within 28 days. Never freeze reconstituted product.

What happened to Peptide Sciences and who should researchers use now?

Peptide Sciences closed voluntarily on March 6, 2026, after roughly 15 years of operation and an estimated $7.4 million per month in sales at closure. The closure appears pre-emptive rather than enforcement-driven, but the effect on supply was the same. Researchers previously sourcing through Peptide Sciences have mostly migrated to Core Peptides, Ascension, or Apollo depending on testing needs and budget.

How does the FDA enforcement environment affect semaglutide vendors in 2026?

The enforcement backdrop is active. The FDA issued 55+ warning letters to GLP-1 compounders in September 2025, raided Amino Asylum in June 2025, and the SAFE Drugs Act introduced in early 2026 would close the research-use-only gray area entirely if passed. Vendors that survived the 2025 thinning did so by tightening documentation, adding CLIA-lab or blind-test validation, and in some cases gating GLP-1 catalogs behind researcher registration. The practical effect: fewer vendors, higher average quality among survivors, and a wider gap between top and bottom tier.

Which vendor should I pick for first-time semaglutide research?

For a first protocol with no specific documentation requirements, Core Peptides is the default. Dual-lab testing with both labs named, 279 verified reviews at 4.8 stars, and standard 5mg lyophilized vials make it the highest trust-per-dollar option. If the work has to survive external review, move up to Ascension for CLIA documentation. If the protocol is GLP-1 only and methodology match matters, Apollo is the specialist pick. See full scorecards in our vendor directory.